Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
October 18, 2016
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules
Jeremy L Yap, Lijia Chen, Maryanna E Lanning, et al.
Oncology Letters
|
June 1, 2018
Therapeutic potential of Bcl-x<sub>L</sub>/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment
Mariarita Perri, Jeremy L Yap, Steven Fletcher, et al.
Chemmedchem
|
November 27, 2010
Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics
Jeremy L Yap, Shilpa Worlikar, Alexander D MacKerell, et al.
Experimental Cell Research
|
August 5, 2014
BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
Mariarita Perri, Jeremy L Yap, Jianshi Yu, et al.
RSC Medicinal Chemistry
|
February 10, 2023
Discovery of <i>N</i>-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors
Lijia Chen, Jay Chauhan, Jeremy L Yap, et al.
Chemmedchem
|
July 1, 2014
Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization
Jay Chauhan, Huabo Wang, Jeremy L Yap, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5
Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Chemmedchem
|
February 5, 2016
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates
Brandon Drennen, Jacob A Scheenstra, Jeremy L Yap, et al.
Organic Letters
|
June 15, 2013
Amphipathic α-helix mimetics based on a 1,2-diphenylacetylene scaffold
Kwan-Young Jung, Kenno Vanommeslaeghe, Maryanna E Lanning, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
October 18, 2016
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules
Jeremy L Yap, Lijia Chen, Maryanna E Lanning, et al.
Oncology Letters
|
June 1, 2018
Therapeutic potential of Bcl-x<sub>L</sub>/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment
Mariarita Perri, Jeremy L Yap, Steven Fletcher, et al.
Chemmedchem
|
November 27, 2010
Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics
Jeremy L Yap, Shilpa Worlikar, Alexander D MacKerell, et al.
Experimental Cell Research
|
August 5, 2014
BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
Mariarita Perri, Jeremy L Yap, Jianshi Yu, et al.
RSC Medicinal Chemistry
|
February 10, 2023
Discovery of <i>N</i>-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors
Lijia Chen, Jay Chauhan, Jeremy L Yap, et al.
Chemmedchem
|
July 1, 2014
Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization
Jay Chauhan, Huabo Wang, Jeremy L Yap, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5
Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Chemmedchem
|
February 5, 2016
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates
Brandon Drennen, Jacob A Scheenstra, Jeremy L Yap, et al.
Organic Letters
|
June 15, 2013
Amphipathic α-helix mimetics based on a 1,2-diphenylacetylene scaffold
Kwan-Young Jung, Kenno Vanommeslaeghe, Maryanna E Lanning, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Page
of 3